|
|
Article: Scientist issues warning over lack of funding for new drugs
- Article from:
- The Northern Echo
- Article date:
- September 4, 2007
- Author:
CopyrightCopyright 2007 The Northern Echo. Provided by ProQuest LLC. (Hide copyright information)
|
A LEADING scientist has warned that big pharmaceutical companies
will pull out of Britain unless the NHS funds more new
drugs.Professor Hilary Calvert, of Newcastle University's Northern
Institute for Cancer Research, suggested that the drug watchdog Nice
was having a damaging effect on the UK pharmaceutical industry.By
refusing to approve new drugs for the NHS that are widely used in
other European countries, he said Nice was driving pharmaceutical
companies abroad. Prof Calvert, who published the first scientific
paper on Alimta, a new drug that can extend the lives of patients
with mesothelioma, said: "It is leading to disinvestment in the UK by
the pharmaceutical companies."If they do ...
Related newspaper, magazine, and journal articles:
|
|
Article: Britain 'could miss out on new drugs'
The Sunday Telegraph London;
January 20, 2008 ;
421 words
... ... Long delays for new drugs to gain approval ... Clinical Excellence (Nice), are making Britain ... increase pressure on Nice to overhaul working ... benefit analysis for new drugs before they have ... continuing to work with Nice to launch new drugs in Britain.
|
|